Bronte Capital: 13F holdings, Q2 2026
Emerging, concentrated · SEC EDGAR filings (CIK 0001471085) · Explore on the interactive board
Bronte Capital disclosed 56 US equity positions worth $888.2m in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 5, 2026). Its largest position is GOOGL at 12.3% of the reported book, followed by REGN, IBKR. The top ten holdings are 74.4% of the book, and the portfolio behaves like about 15 equal-weight positions. Versus the prior filing it opened 15 new positions, added to 7, reduced 33 and exited 10.
What does Bronte Capital own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 15 new, 7 added, 33 reduced, 10 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | GOOGL ALPHABET INC | Communication Services | 12.3% | $109.1m | 305,165 | -20% | reduced |
| 2 | REGN REGENERON PHARMACEUTICALS | Healthcare | 11.4% | $101.4m | 162,618 | -6% | reduced |
| 3 | IBKR INTERACTIVE BROKERS GROUP | Financial Services | 8.7% | $76.9m | 883,526 | -31% | reduced |
| 4 | VISA INC-CLASS A SHARES | 8.5% | $75.5m | 219,914 | -8% | reduced | |
| 5 | BRK/B BERKSHIRE HATHAWAY INC DEL | 8.2% | $73.0m | 145,847 | -6% | reduced | |
| 6 | AMZN AMAZON COM INC | Consumer Cyclical | 7.0% | $62.3m | 261,433 | -9% | reduced |
| 7 | PM PHILIP MORRIS INTL INC | Consumer Defensive | 6.1% | $54.3m | 300,176 | -12% | reduced |
| 8 | CTVA CORTEVA INC | Basic Materials | 4.4% | $38.7m | 456,656 | -9% | reduced |
| 9 | COF CAPITAL ONE FINL CORP | Financial Services | 3.9% | $34.8m | 173,523 | -7% | reduced |
| 10 | DIS DISNEY WALT CO | Communication Services | 3.9% | $34.7m | 360,243 | 94% | added |
| 11 | FCNCA FIRST CTZNS BANCSHARES INC N | Financial Services | 3.3% | $29.5m | 14,179 | -14% | reduced |
| 12 | TBBB BBB FOODS INC | Consumer Defensive | 2.5% | $22.2m | 533,151 | 9% | added |
| 13 | AURORA INNOVATION INC | 1.7% | $14.9m | 2,186,821 | -6% | reduced | |
| 14 | VANECK ETF TRUST | 1.6% | $14.5m | 191,580 | -8% | reduced | |
| 15 | SOTERA HEALTH CO | 1.6% | $14.1m | 797,138 | -6% | reduced | |
| 16 | NKTR NEKTAR THERAPEUTICS | Healthcare | 1.6% | $13.9m | 198,434 | 0% | held |
| 17 | GHC GRAHAM HLDGS CO | Industrials | 1.5% | $13.1m | 11,454 | -10% | reduced |
| 18 | IBB ISHARES TR | 1.4% | $12.5m | 65,807 | -5% | reduced | |
| 19 | BF/B BROWN FORMAN CORP | 1.4% | $12.4m | 464,313 | – | new | |
| 20 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 1.2% | $10.7m | 35,384 | -5% | reduced |
| 21 | SQM SOCIEDAD QUIMICA Y MINERA DE | Basic Materials | 1.0% | $8.6m | 116,308 | -5% | reduced |
| 22 | GLBE GLOBAL E ONLINE LTD | Consumer Cyclical | 0.9% | $7.9m | 227,644 | 7% | added |
| 23 | NEM NEWMONT CORP | Basic Materials | 0.7% | $6.5m | 69,494 | -8% | reduced |
| 24 | B BARRICK MNG CORP | Basic Materials | 0.6% | $5.4m | 146,359 | -8% | reduced |
| 25 | RAMP LIVERAMP HLDGS INC | Technology | 0.5% | $4.8m | 128,348 | -43% | reduced |
| 26 | HLF HERBALIFE NUTRITION LTD | Consumer Defensive | 0.5% | $4.3m | 323,386 | -66% | reduced |
| 27 | RVMD REVOLUTION MEDICINES INC | Healthcare | 0.4% | $3.5m | 18,780 | – | new |
| 28 | TPB TURNING PT BRANDS INC | Consumer Defensive | 0.4% | $3.5m | 40,721 | -5% | reduced |
| 29 | ISHARES TR | 0.4% | $3.4m | 23,004 | – | new | |
| 30 | BBWI BATH & BODY WORKS INC | Consumer Cyclical | 0.4% | $3.3m | 143,800 | -8% | reduced |
| 31 | MDLZ MONDELEZ INTL INC | Consumer Defensive | 0.3% | $3.1m | 53,234 | -5% | reduced |
| 32 | RSKD RISKIFIED LTD | Technology | 0.3% | $3.0m | 588,251 | 20% | added |
| 33 | BF/A BROWN FORMAN CORP | 0.3% | $2.6m | 95,365 | -5% | reduced | |
| 34 | TYL TYLER TECHNOLOGIES INC | Technology | 0.3% | $2.4m | 8,302 | – | new |
| 35 | VANECK ETF TRUST | 0.3% | $2.4m | 24,568 | -8% | reduced | |
| 36 | PCTY PAYLOCITY HLDG CORP | Technology | 0.2% | $1.9m | 17,874 | -51% | reduced |
| 37 | NICE NICE LTD | Technology | 0.2% | $1.5m | 16,396 | -4% | reduced |
| 38 | OLED UNIVERSAL DISPLAY CORP | Technology | 0.1% | $889.2k | 10,269 | -8% | reduced |
| 39 | VRSK VERISK ANALYTICS INC | Industrials | 0.1% | $481.5k | 2,682 | -8% | reduced |
| 40 | TMCI TREACE MED CONCEPTS INC | Healthcare | 0.0% | $62.0k | 15,577 | – | new |
| 41 | FATE FATE THERAPEUTICS INC | Healthcare | 0.0% | $58.7k | 21,740 | -5% | reduced |
| 42 | ANTX AN2 THERAPEUTICS INC | 0.0% | $52.7k | 10,895 | – | new | |
| 43 | CCCC C4 THERAPEUTICS INC | Healthcare | 0.0% | $48.3k | 10,349 | 3% | added |
| 44 | ENVX ENOVIX CORPORATION | Industrials | 0.0% | $45.6k | 41,765 | 262% | added |
| 45 | ALXO ALX ONCOLOGY HLDGS INC | Healthcare | 0.0% | $37.5k | 18,095 | – | new |
| 46 | BLND BLEND LABS INC | 0.0% | $32.9k | 19,247 | – | new | |
| 47 | PEPG PEPGEN INC | Healthcare | 0.0% | $32.0k | 17,776 | – | new |
| 48 | CMRC COMMERCE.COM INC | Technology | 0.0% | $30.4k | 10,278 | – | new |
| 49 | PACB PACIFIC BIOSCIENCES CALIF IN | Healthcare | 0.0% | $30.0k | 17,881 | – | new |
| 50 | ABOS ACUMEN PHARMACEUTICALS INC | 0.0% | $28.6k | 10,716 | – | new |
What did Bronte Capital sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| BROWN FORMAN CORP | 34.3% | $13.1m |
| ISHARES TR | 31.0% | $11.8m |
| PINS PINTEREST INC | 20.8% | $7.9m |
| SBH SALLY BEAUTY HLDGS INC | 8.0% | $3.1m |
| JAMES RIV GROUP HOLDINGS INC | 5.6% | $2.1m |
| CRBU CARIBOU BIOSCIENCES INC | 0.1% | $29.7k |
| PLRX PLIANT THERAPEUTICS INC | 0.1% | $23.5k |
| IVVD INVIVYD INC | 0.0% | $14.3k |
| RANI RANI THERAPEUTICS HLDGS INC | 0.0% | $10.9k |
| GUTS FRACTYL HEALTH INC | 0.0% | $7.7k |
Sector mix
| Sector | Weight |
|---|---|
| Communication Services | 16.2% |
| Financial Services | 15.9% |
| Healthcare | 14.6% |
| Consumer Defensive | 9.8% |
| Consumer Cyclical | 8.3% |
| Basic Materials | 6.7% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
| Quarter | Positions | Equity value |
|---|---|---|
| Q2 2026 | 57 | $888.2m |
| Q1 2026 | 51 | $940.9m |
| Q4 2025 | 43 | $956.8m |
| Q3 2025 | 29 | $1.1bn |
| Q2 2025 | 27 | $1.3bn |
| Q1 2025 | 26 | $1.2bn |
| Q4 2024 | 24 | $1.3bn |
| Q3 2024 | 25 | $1.2bn |
| Q2 2024 | 28 | $1.3bn |
| Q1 2024 | 29 | $1.2bn |
| Q4 2023 | 29 | $1.1bn |
| Q3 2023 | 28 | $992.8m |
| Q2 2023 | 32 | $1.0bn |
| Q1 2023 | 30 | $861.9m |
| Q4 2022 | 27 | $792.6m |
| Q3 2022 | 28 | $802.9m |
Earliest filing: Q4 2018 · 31 quarters on file
How concentrated is Bronte Capital's portfolio?
Across every quarter Bronte Capital has filed, its median largest position is 14.8% of the book and its median top-ten weight is 79.8%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 49 completed holding spells, the median lasted 3.0 quarters; 56 positions are still open and their final length is unknown.